Oxyberberine Ameliorates Type 2 Diabetic Osteoporosis Through Sirtuin 3‐Associated Regulation of Autophagy and Ferroptosis in Bone Marrow Mesenchymal Stem Cells
Phytotherapy Research · 2026-11-09
DOI: 10.1002/ptr.70511 ↗At a glance
Journal article in Phytotherapy Research, published online on 2026-11-09. Written by Jianan Huang and 10 co-authors. Institution: State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, …. 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Science and Technology Bureau of Xinjiang Production and Construction Corps, China, Guangzhou Municipal Health Commission, China.
Abstract (original language)
Type 2 diabetic osteoporosis (T2DOP) is characterized by impaired bone formation and dysfunction of bone marrow mesenchymal stem cells (BMSCs) under persistent metabolic stress. This study investigated the osteoprotective effects of Oxyberberine (OBB) and the involvement of sirtuin 3 (Sirt3)‐associated autophagy and ferroptosis. A high‐fat diet/streptozotocin‐induced T2DOP mouse model and high‐glucose‐treated BMSCs were used. Integrated omics, UHPLC‐HRMS, molecular docking, molecular dynamics simulation, and cellular thermal shift assays were used for compound and target evaluation. Osteogenesis, autophagy, oxidative stress, and ferroptosis were assessed using histological, biochemical, fluorescence, and molecular assays. Sirt3 was suppressed using shRNA in BMSCs and systemic adeno‐associated virus‐mediated knockdown in mice. Ferrostatin‐1 was used as a ferroptosis inhibitor. OBB improved trabecular bone microarchitecture and osteogenic indices in T2DOP mice. In high‐glucose‐treated BMSCs, OBB enhanced osteogenic differentiation and autophagy‐associated activity while reducing reactive oxygen species, Fe 2+ accumulation, lipid peroxidation, and mitochondrial abnormalities. OBB also decreased Ac‐SOD2/SOD2 and Ac‐FoxO3a/FoxO3a ratios. Autophagy inhibition weakened the anti‐ferroptotic effects of OBB, whereas Ferrostatin‐1 partially reproduced its anti‐ferroptotic and pro‐osteogenic effects. Sirt3 knockdown attenuated OBB‐associated protective effects in vitro and reduced skeletal protection in vivo. OBB ameliorates diabetic bone deterioration and high‐glucose‐induced BMSC dysfunction, with Sirt3‐associated regulation of autophagy, redox homeostasis, and ferroptosis contributing to its effects. These findings support further evaluation of OBB as a potential pharmacological candidate for T2DOP.
Subjects
Author keywords
Authors and institutions
- State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- The First Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, People's Republic of China.
- Fifth School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- Department of Orthopaedics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.
- Hongxing Hospital of the 13th Division of Xinjiang Production and Construction Corps, Hami, People's Republic of China.
ORCID profiles: Jianan Huang, Hua Zhang, Junzheng Yang, Baohua Wang, Peng Chen
Funding
- National Natural Science Foundation of China
- Science and Technology Bureau of Xinjiang Production and Construction Corps, China
- Guangzhou Municipal Health Commission, China
- Guangdong Provincial Administration of Traditional Chinese Medicine, China
- Open Research Project of the Key Laboratory of Lingnan Traditional Chinese Medicine Resources (Ministry of Education)
- Guangzhou University of Chinese Medicine, China
Cite
APA
Huang, J., Chen, B., Zhang, H., Yang, J., Xiao, J., Meng, C., An, Y., Meng, K., Wang, B., An, Z., & Chen, P. (2026). Oxyberberine Ameliorates Type 2 Diabetic Osteoporosis Through Sirtuin 3‐Associated Regulation of Autophagy and Ferroptosis in Bone Marrow Mesenchymal Stem Cells. Phytotherapy Research. https://doi.org/10.1002/ptr.70511
Vancouver
Huang J, Chen B, Zhang H, Yang J, Xiao J, Meng C, et al. Oxyberberine Ameliorates Type 2 Diabetic Osteoporosis Through Sirtuin 3‐Associated Regulation of Autophagy and Ferroptosis in Bone Marrow Mesenchymal Stem Cells. Phytotherapy Research. 2026. doi:10.1002/ptr.70511
BibTeX
@article{Huang2026,
author = {Huang, Jianan and Chen, Baihao and Zhang, Hua and Yang, Junzheng and Xiao, Jiacong and Meng, Chenhui and An, Yanchao and Meng, Kai and Wang, Baohua and An, Zhantian and Chen, Peng},
title = {Oxyberberine Ameliorates Type 2 Diabetic Osteoporosis Through Sirtuin 3‐Associated Regulation of Autophagy and Ferroptosis in Bone Marrow Mesenchymal Stem Cells},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70511}
}
EUVIMED